Quantitation of a 36-amino-acid peptide inhibitor of HIV-1 membrane fusion in animal and human plasma using high-performance liquid chromatography and fluorescence detection.
Selective extraction of a 36-amino-acid peptide (DP-178, T20, pentafuside) from the protein matrices of animal and human plasma was achieved using acetonitrile containing 1% trifluoroacetic acid and 1% n-nonyl-beta-D-glucopyranoside. The peptide concentration of the extract was measured using reversed-phase high-performance liquid chromatography (RP-HPLC) and fluorescence detection. The eluent was excited at 280 nm and the intrinsic fluorescence signal was collected at 350 nm. Recovery of T20 from the plasma matrices was 75% (mouse), 60% (rat), 50% (cynomolgus monkey), and 55% (human) based on parallel-processed aqueous T20 standard solutions. The fluorescence peak area vs. concentration of T20 was linear in the range 4-160 ng/ml based on the final solute concentration in the HPLC vial, corresponding to original plasma concentrations of 100-4000 ng/ml. Experiments with truncated analogs of T20 demonstrate that this assay offers the advantage of detecting metabolites attributable to bio-transformation degradation processes differing by as little as one amino acid from the original peptide.